Skip to main content
SpringerLink
Log in

Vasookklusive Retinitis nach Brolucizumab-Injektion

Vaso-occlusive retinitis following intravitreal injection of brolucizumab

  • Kasuistiken
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Baumal CR, Spaide RF, Vajzovic L et al (2020) Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab. Ophthalmology. https://doi.org/10.1016/j.ophtha.2020.04.017

    Article  PubMed  Google Scholar 

  2. Witkin AJ, Hahn P, Murray TG et al (2020) Occlusive retinal vasculitis following intravitreal brolucizumab. J Vitreoretin Dis 4(4):269–279. https://doi.org/10.1177/2474126420930863

    Article  PubMed  PubMed Central  Google Scholar 

  3. Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, Mamalis N, Miller KM, Wykoff CC (2017) Vancomycin-associated hemorrhagic occlusive retinal Vasculitis: clinical characteristics of 36 eyes. Ophthalmology 124(5):583–595. https://doi.org/10.1016/j.ophtha.2016.11.042

    Article  PubMed  Google Scholar 

  4. Haug SJ, Hien DL, Uludag G et al (2020) Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration. Am J Ophthalmol Case Rep. https://doi.org/10.1016/j.ajoc.2020.100680

    Article  PubMed  PubMed Central  Google Scholar 

  5. https://www.novartis.com/news/media-releases/european-medicines-agency-ema-approves-safety-label-update-novartis-beovu. Zugegriffen: 15. Sept. 2020

  6. Rosenfeld PJ, Browning DJ (2020) Is this a 737 Max moment for brolucizumab? Am J Ophthalmol 216:A7–A8. https://doi.org/10.1016/j.ajo.2020.05.012

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenklinik, Ortenauklinikum Offenburg, Weingartenstr. 70, 77654, Offenburg, Deutschland

    Maximillian Peter Michael Angerer, Konrad Hille &  Peter Christian Horn

  2. Augenärzte Achern, Achern, Deutschland

    Matthias Neuburger

Authors
  1. Maximillian Peter Michael Angerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Neuburger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Konrad Hille
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Christian Horn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Christian Horn.

Ethics declarations

Interessenkonflikt

M.P.M. Angerer, M. Neuburger, K. Hille und P.C. Horn geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Angerer, M.P.M., Neuburger, M., Hille, K. et al. Vasookklusive Retinitis nach Brolucizumab-Injektion. Ophthalmologe 118, 1048–1050 (2021). https://doi.org/10.1007/s00347-020-01253-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-020-01253-9

Search

Navigation